This inventor holds 1 USPTO granted patent. Top assignee: Targacept, Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Gary Dwight Byrd: Innovator in Pharmaceutical Compositions
Introduction
Gary Dwight Byrd is a notable inventor based in Winston-Salem, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent.
Latest Patents
Gary Byrd holds a patent for "Oxopyridinyl pharmaceutical compositions and methods for use." This patent includes pharmaceutical compositions that incorporate aryl substituted olefinic amine compounds. Representative compounds in his patent are (2S)-(4E)-N-methyl-5-[3-(5-isopropoxy-1-oxopyridin)yl]-4-penten-2-amine, (4E)-N-methyl-5-(3-(1-oxopyridin)yl)-4-penten-2-amine, (4E)-N-methyl-5-(3-(5-((carboxymethyl)oxy)pyridin)yl)-4-penten-2-amine, and (4E)-N-methyl-5-(3-(1-oxopyridin)yl)-4-penten-2-amine. He has a total of 1 patent.
Career Highlights
Gary Byrd is associated with Targacept, Inc., where he has been able to apply his expertise in pharmaceutical innovations. His work has contributed to advancements in drug development and therapeutic applications.
Collaborations
Some of his notable coworkers include Craig Harrison Miller and Dwo Lynm. Their collaborative efforts have further enhanced the research and development initiatives at Targacept, Inc.
Conclusion
Gary Dwight Byrd is a distinguished inventor whose work in pharmaceutical compositions has made a significant impact in the industry. His innovative approaches continue to pave the way for advancements in healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile